Literature DB >> 33465066

Modeling the structure of the frameshift-stimulatory pseudoknot in SARS-CoV-2 reveals multiple possible conformers.

Sara Ibrahim Omar1,2, Meng Zhao1, Rohith Vedhthaanth Sekar1, Sahar Arbabi Moghadam1, Jack A Tuszynski1,2, Michael T Woodside1.   

Abstract

The coronavirus causing the COVID-19 pandemic, SARS-CoV-2, uses -1 programmed ribosomal frameshifting (-1 PRF) to control the relative expression of viral proteins. As modulating -1 PRF can inhibit viral replication, the RNA pseudoknot stimulating -1 PRF may be a fruitful target for therapeutics treating COVID-19. We modeled the unusual 3-stem structure of the stimulatory pseudoknot of SARS-CoV-2 computationally, using multiple blind structural prediction tools followed by μs-long molecular dynamics simulations. The results were compared for consistency with nuclease-protection assays and single-molecule force spectroscopy measurements of the SARS-CoV-1 pseudoknot, to determine the most likely conformations. We found several possible conformations for the SARS-CoV-2 pseudoknot, all having an extended stem 3 but with different packing of stems 1 and 2. Several conformations featured rarely-seen threading of a single strand through junctions formed between two helices. These structural models may help interpret future experiments and support efforts to discover ligands inhibiting -1 PRF in SARS-CoV-2.

Entities:  

Year:  2021        PMID: 33465066     DOI: 10.1371/journal.pcbi.1008603

Source DB:  PubMed          Journal:  PLoS Comput Biol        ISSN: 1553-734X            Impact factor:   4.475


  13 in total

1.  Crystal structure of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) frameshifting pseudoknot.

Authors:  Christopher P Jones; Adrian R Ferré-D'Amaré
Journal:  RNA       Date:  2021-11-29       Impact factor: 4.942

2.  RNAspider: a webserver to analyze entanglements in RNA 3D structures.

Authors:  Kamil Luwanski; Vladyslav Hlushchenko; Mariusz Popenda; Tomasz Zok; Joanna Sarzynska; Daniil Martsich; Marta Szachniuk; Maciej Antczak
Journal:  Nucleic Acids Res       Date:  2022-03-29       Impact factor: 19.160

3.  Length-dependent motions of SARS-CoV-2 frameshifting RNA pseudoknot and alternative conformations suggest avenues for frameshifting suppression.

Authors:  Shuting Yan; Qiyao Zhu; Swati Jain; Tamar Schlick
Journal:  Res Sq       Date:  2022-01-04

4.  Identifying Inhibitors of -1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses.

Authors:  Sneha Munshi; Krishna Neupane; Sandaru M Ileperuma; Matthew T J Halma; Jamie A Kelly; Clarissa F Halpern; Jonathan D Dinman; Sarah Loerch; Michael T Woodside
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.818

5.  Geneticin shows selective antiviral activity against SARS-CoV-2 by targeting programmed -1 ribosomal frameshifting.

Authors:  Carmine Varricchio; Gregory Mathez; Laurent Kaiser; Caroline Tapparel; Andrea Brancale; Valeria Cagno
Journal:  bioRxiv       Date:  2022-03-08

Review 6.  Thinking Outside the Frame: Impacting Genomes Capacity by Programmed Ribosomal Frameshifting.

Authors:  Ricarda J Riegger; Neva Caliskan
Journal:  Front Mol Biosci       Date:  2022-02-14

Review 7.  Programmed -1 ribosomal frameshifting from the perspective of the conformational dynamics of mRNA and ribosomes.

Authors:  Kai-Chun Chang; Jin-Der Wen
Journal:  Comput Struct Biotechnol J       Date:  2021-06-14       Impact factor: 7.271

8.  A map of the SARS-CoV-2 RNA structurome.

Authors:  Ryan J Andrews; Collin A O'Leary; Van S Tompkins; Jake M Peterson; Hafeez S Haniff; Christopher Williams; Matthew D Disney; Walter N Moss
Journal:  NAR Genom Bioinform       Date:  2021-05-22

9.  Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.

Authors:  Jamie A Kelly; Michael T Woodside; Jonathan D Dinman
Journal:  Virology       Date:  2020-12-25       Impact factor: 3.513

10.  Structural dynamics of single SARS-CoV-2 pseudoknot molecules reveal topologically distinct conformers.

Authors:  Krishna Neupane; Meng Zhao; Aaron Lyons; Sneha Munshi; Sandaru M Ileperuma; Dustin B Ritchie; Noel Q Hoffer; Abhishek Narayan; Michael T Woodside
Journal:  Nat Commun       Date:  2021-08-06       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.